Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
b.kertusha@uniroma1.it
Blerta Kertusha
Dottorando
Struttura:
DIPARTIMENTO DI SANITA' PUBBLICA E MALATTIE INFETTIVE
E-mail:
b.kertusha@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli
VIRUSES
2023
Use of remdesivir in patients with SARS-CoV-2 Pneumonia in a real-life setting during the second and third COVID-19 epidemic waves
VIRUSES
2023
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use
VIRUSES
2023
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use
VIRUSES
2023
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
FRONTIERS IN IMMUNOLOGY
2022
Longitudinal virological and immunological profile in a case of human monkeypox infection
OPEN FORUM INFECTIOUS DISEASES
2022
Quality of t-cell response to sars-cov-2 mrna vaccine in art-treated plwh
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?
THE JOURNAL OF HOSPITAL INFECTION
2021
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia
FRONTIERS IN IMMUNOLOGY
2021
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study
PLOS ONE
2021
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II)
CARDIOVASCULAR DIABETOLOGY
2020
Epidemiology and microbiology of skin and soft tissue infections: preliminary results of a National registry
JOURNAL OF CHEMOTHERAPY
2019
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
PLOS ONE
2018
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma